Twist Bioscience Reports Fourth Quarter and Full Year Fiscal 2019 Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/18/2026
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Oil slides after China asks Iran to limit Houthi attacks on Saudi oil facilities
- Warren Buffett transitions to Berkshire’s chairman emeritus
- Is the S&P 500 in an "earnings bubble"? Goldman weighs in
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
Twist Bioscience Corporation (TWST) Misses Q4 EPS by 11c
December 11, 2019 4:11 PM ESTTwist Bioscience Corporation (NASDAQ: TWST) reported Q4 EPS of ($0.96), $0.11 worse than the analyst estimate of ($0.85). Revenue for the quarter came in at $15.7 million versus the consensus estimate of $14.06 million.
GUIDANCE:
Twist Bioscience Corporation sees FY2020 revenue of $80-84 million, versus... More
